JP Morgan Reiterates Neutral Rating on Hormel Foods Corporation (HRL)
JP Morgan reiterated its Neutral rating on Hormel Foods Corporation (NYSE:HRL) on August 14, 2026.
Read moreReal-time context
Upgrades, downgrades, initiations, and price-target changes.
JP Morgan reiterated its Neutral rating on Hormel Foods Corporation (NYSE:HRL) on August 14, 2026.
Read moreTruist Securities reiterated its Buy rating on Dynatrace, Inc. (NYSE:DT) on August 14, 2026.
Read moreBarclays reiterated its Overweight rating on Ascendis Pharma A/S (NASDAQ:ASND) on August 14, 2026.
Read moreTD Cowen reiterated its Buy rating on Ascendis Pharma A/S (NASDAQ:ASND) on August 14, 2026.
Read moreRBC Capital reiterated its Outperform rating on Ascendis Pharma A/S (NASDAQ:ASND) on August 14, 2026.
Read moreUBS reiterated its Buy rating on Performance Food Group Company (NYSE:PFGC) on August 14, 2026.
Read moreBernstein reiterated its Market Perform rating on Rockwell Automation, Inc. (NYSE:ROK) on August 14, 2026.
Read moreBenchmark reiterated its Buy rating on Cineverse Corp. (NASDAQ:CNVS) on August 14, 2026.
Read moreB of A Securities reiterated its Neutral rating on Candel Therapeutics, Inc. (NASDAQ:CADL) on August 14, 2026.
Read moreRBC Capital reiterated its Outperform rating on MeiraGTx Holdings plc (NASDAQ:MGTX) on August 14, 2026.
Read moreJP Morgan reiterated its Overweight rating on Relay Therapeutics, Inc. (NASDAQ:RLAY) on August 14, 2026.
Read moreMacquarie reiterated its Outperform rating on Fermi Inc. Common Stock (NASDAQ:FRMI) on August 14, 2026.
Read moreHC Wainwright & Co. reiterated its Buy rating on Avidity Biosciences, Inc.
Read moreJP Morgan analysts upgraded Fox Corporation (NASDAQ:FOX) from Neutral to Overweight on August 14, 2026.
Read moreWells Fargo analysts upgraded Fox Corporation (NASDAQ:FOX) from Equal-Weight to Overweight on August 14, 2026.
Read moreLeerink Partners analysts initiated coverage on Ligand Pharmaceuticals, Inc. (OTC:LGNXZ) with a rating of Outperform on August 14, 2026.
Read moreMaxim Group reiterated its Buy rating on Health In Tech, Inc. (NASDAQ:HIT) on August 14, 2026.
Read moreLake Street reiterated its Buy rating on Sensus Healthcare, Inc. (NASDAQ:SRTS) on August 14, 2026.
Read moreNeedham reiterated its Buy rating on Veritone, Inc. (NASDAQ:VERI) on August 14, 2026.
Read moreCanaccord Genuity reiterated its Buy rating on Kopin Corp (NASDAQ:KOPN) on August 14, 2026.
Read more